Charles Schwab Investment Management Inc Mei Pharma, Inc. Transaction History

Charles Schwab Investment Management Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.42 - $0.65 $287,186 - $444,455	-683,777 Reduced 93.12%	50,519 $31,000
Q1 2022 May 13, 2022	BUY	$0.54 - $2.74 $25,383 - $128,796	47,006 Added 6.84%	734,296 $443,000
Q4 2021 Feb 11, 2022	SELL	$2.33 - $3.37 $249,664 - $361,102	-107,152 Reduced 13.49%	687,290 $1.84 Million
Q3 2021 Nov 16, 2021	BUY	$2.52 - $2.99 $47,411 - $56,253	18,814 Added 2.43%	794,442 $2.19 Million
Q2 2021 Aug 16, 2021	SELL	$2.6 - $3.65 $25,056 - $35,175	-9,637 Reduced 1.23%	775,628 $2.21 Million
Q1 2021 May 17, 2021	BUY	$2.73 - $4.5 $23,366 - $38,515	8,559 Added 1.1%	785,265 $2.69 Million
Q4 2020 Feb 16, 2021	BUY	$2.6 - $3.32 $347,386 - $443,585	133,610 Added 20.78%	776,706 $2.05 Million
Q3 2020 Nov 13, 2020	BUY	$2.46 - $4.27 $954,959 - $1.66 Million	388,195 Added 152.29%	643,096 $2.01 Million
Q2 2020 Aug 14, 2020	BUY	$1.45 - $4.3 $34,539 - $102,426	23,820 Added 10.31%	254,901 $1.05 Million
Q1 2020 May 15, 2020	BUY	$0.75 - $2.55 $45,796 - $155,708	61,062 Added 35.91%	231,081 $372,000
Q4 2019 Feb 07, 2020	BUY	$1.65 - $2.48 $21,634 - $32,517	13,112 Added 8.36%	170,019 $422,000
Q2 2019 Aug 09, 2019	BUY	$2.45 - $3.32 $347,113 - $470,374	141,679 Added 930.38%	156,907 $393,000
Q1 2019 May 14, 2019	BUY	$2.52 - $3.24 $38,374 - $49,338	15,228 New	15,228 $47,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $385M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.